Eight Biopharmaceuticals

Eight Biopharmaceuticals is a biotechnology company focused on developing a new generation of antibody therapeutics targeting G protein-coupled receptors (GPCRs). The company leverages a proprietary platform designed to overcome historical challenges in generating highly specific and potent antibodies against complex GPCR targets, which are traditionally difficult to drug with biologics. Their current research and development efforts are primarily directed toward addressing unmet needs in immunology, inflammation, and metabolic disorders. By combining deep expertise in GPCR biology with advanced antibody engineering, Eight Biopharmaceuticals aims to create precision medicines with improved safety and efficacy profiles compared to existing small molecule treatments.